Mechanisms underlying pathological angiogenesis in relation to hypoxia in tumor invasion and metastasis remain elusive. Here, we have developed a zebrafish tumor model that allows us to study the role of pathological angiogenesis under normoxia and hypoxia in arbitrating early events of the metastatic cascade at the single cell level. Under normoxia, implantation of a murine T241 fibrosarcoma into the perivitelline cavity of developing embryos of transgenic fli1:EGFP zebrafish did not result in significant dissemination, invasion, and metastasis. In marked contrast, under hypoxia substantial tumor cells disseminated from primary sites, invaded into neighboring tissues, and metastasized to distal parts of the fish body. Similarly, expression of the hypoxia-regulated angiogenic factor, vascular endothelial growth factor (VEGF) to a high level resulted in tumor cell dissemination and metastasis, which correlated with increased tumor neovascularization. Inhibition of VEGF receptor signaling pathways by sunitinib or VEGFR2 morpholinos virtually completely ablated VEGFinduced tumor cell dissemination and metastasis. To the best of our knowledge, hypoxia-and VEGF-induced pathological angiogenesis in promoting tumor dissemination, invasion, and metastasis has not been described perviously at the single cell level. Our findings also shed light on molecular mechanisms of beneficial effects of clinically available anti-VEGF drugs for cancer therapy.hypoxia ͉ tumor invasion ͉ VEGF A ngiogenesis not only is essential for primary tumor growth but also facilitates tumor invasion and metastasis (1, 2). Tumor microvascular networks possess several unique pathological features distinguishing them from healthy blood vessels. These include extremely high densities of leaky, tortuous, and primitive microvessels that usually lack pericyte coverage, basement membrane, and arteriole-venule distinctions (3-6). These unusual features often create a hypoxic environment owning to poor blood perfusion, high interstitial fluid pressure (IFP), acidosis, and fast growth as well as metabolic rates of malignant tissues (7,8). Although hypoxia often results in necrosis of the central core of a fast-growing tumor, it could potentially persuade tumor cells to invade neighboring healthy vasculatures for survival, eventually leading to metastasis, which is one of the hallmarks for cancer therapy (9-13).Recent studies show that antiangiogenic drugs and vascular destructive agents also promote tumor cell invasion and metastasis in association with drug-induced tumor hypoxia (14-16). However, molecular mechanisms and detailed processes underlying hypoxiaassociated metastasis remain poorly understood. A clinical detectable metastatic mass often represents an ultimate consequence of several distinctive steps of the metastatic cascade, including dissemination of malignant cells from the primary site, transport of tumor cells via the circulation or lymphatic system, adhesion of tumor cells in distal tissues/organs, and re-growth of tumor cells into a detect...